Globeflex Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-25,563
| Closed | -$643K | – | 488 |
|
|
2020
Q4 | $643K | Buy |
25,563
+64
| +0.3% | +$1.61K | 0.14% | 244 |
|
|
2020
Q3 | $531K | Hold |
25,499
| – | – | 0.14% | 244 |
|
|
2020
Q2 | $606K | Buy |
25,499
+4,472
| +21% | +$106K | 0.15% | 233 |
|
|
2020
Q1 | $378K | Hold |
21,027
| – | – | 0.12% | 279 |
|
|
2019
Q4 | $499K | Sell |
21,027
-812
| -4% | -$19.3K | 0.09% | 317 |
|
|
2019
Q3 | $600K | Sell |
21,839
-4,700
| -18% | -$129K | 0.13% | 259 |
|
|
2019
Q2 | $878K | Sell |
26,539
-22
| -0.1% | -$728 | 0.18% | 186 |
|
|
2019
Q1 | $931K | Sell |
26,561
-658
| -2% | -$23.1K | 0.2% | 177 |
|
|
2018
Q4 | $904K | Sell |
27,219
-7,742
| -22% | -$257K | 0.22% | 155 |
|
|
2018
Q3 | $1.76M | Sell |
34,961
-400
| -1% | -$20.1K | 0.35% | 85 |
|
|
2018
Q2 | $2.12M | Sell |
35,361
-2,800
| -7% | -$168K | 0.43% | 51 |
|
|
2018
Q1 | $1.75M | Buy |
38,161
+19,100
| +100% | +$875K | 0.37% | 76 |
|
|
2017
Q4 | $760K | Hold |
19,061
| – | – | 0.21% | 180 |
|
|
2017
Q3 | $762K | Buy |
19,061
+5,700
| +43% | +$228K | 0.22% | 172 |
|
|
2017
Q2 | $576K | Hold |
13,361
| – | – | 0.14% | 227 |
|
|
2017
Q1 | $418K | Hold |
13,361
| – | – | 0.1% | 294 |
|
|
2016
Q4 | $337K | Buy |
+13,361
| New | +$337K | 0.08% | 306 |
|
|
2016
Q1 | – | Sell |
-17,278
| Closed | -$232K | – | 493 |
|
|
2015
Q4 | $232K | Hold |
17,278
| – | – | 0.06% | 302 |
|
|
2015
Q3 | $242K | Sell |
17,278
-84,300
| -83% | -$1.18M | 0.05% | 362 |
|
|
2015
Q2 | $1.73M | Buy |
101,578
+101,514
| +158,616% | +$1.72M | 0.32% | 82 |
|
|
2015
Q1 | $1K | Sell |
64
-30
| -32% | -$469 | ﹤0.01% | 468 |
|
|
2014
Q4 | $1K | Sell |
94
-16
| -15% | -$170 | ﹤0.01% | 466 |
|
|
2014
Q3 | $1K | Buy |
+110
| New | +$1K | ﹤0.01% | 484 |
|